Efficacy and Safety of TJ-100 in the Treatment of Chronic Constipation
NCT ID: NCT00522093
Last Updated: 2011-08-23
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
60 participants
INTERVENTIONAL
2007-08-31
2008-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Acupuncture and Post-Operative Ileus
NCT00655317
Safety and Efficacy of TU-100 as an Adjunct to an Enhanced Recovery After Surgery in Subjects Undergoing Bowel Resection
NCT04742907
Effect of Agar Administration on Defecation and Fecal Condition in Chronic Constipated Patients
NCT02012543
Effect of Non-invasive Neuromodulation on the Quality of Intestinal Cleansing
NCT07290816
Effect of Acupuncture and Herbal Medicine on Bowel Recovery After Abdominal Surgery
NCT07081802
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
SINGLE_GROUP
TREATMENT
NONE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
TJ-100
TJ-100 2.5g three times per day for 6 weeks
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* had symptoms of abdominal bloating or discomfort
Exclusion Criteria
* clinically systemic disease-induced constipation
* pregnancy
20 Years
89 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Tsumura USA
INDUSTRY
Showa Inan General Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Akira Horiuchi
Digestive Disease Center
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Akira Horiuchi, M.D.
Role: PRINCIPAL_INVESTIGATOR
Showa Inan General Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Showa Inan General Hospital
Komagane, , Japan
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
TJ-100
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.